Alain J. Cohen

Insider Reports History

Entity
Individual
Location
7255 Woodmont Ave, Bethesda, Maryland
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alain J. Cohen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Director Common Stock 1.8M $11.8M $6.52 Apr 4, 2022 By Alain J. Cohen Revocable Trust
C4 Therapeutics, Inc. Director Common Stock 928 $6.05K $6.52 Apr 4, 2022 Direct

Insider Reports Filed by Alain J. Cohen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CCCC C4 Therapeutics, Inc. Apr 4, 2022 1 $10.3K 4 Apr 5, 2022 Director
CCCC C4 Therapeutics, Inc. Jan 4, 2022 1 $10K 4 Jan 18, 2022 Director
CCCC C4 Therapeutics, Inc. Oct 4, 2021 1 $9.99K 4 Oct 5, 2021 Director
CCCC C4 Therapeutics, Inc. Jul 2, 2021 1 $9.97K 4 Jul 7, 2021 Director
CCCC C4 Therapeutics, Inc. Jun 15, 2021 1 $0 4 Jun 17, 2021 Director
CCCC C4 Therapeutics, Inc. Jun 14, 2021 2 $0 4 Jun 14, 2021 Director